Research

The EAN has published a new guideline on the management of ALS in collaboration with the European Reference Network for Neuromuscular Diseases.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2024.

Our paper of the month for April is the latest work by the Global Burden of Diseases Collaborator Network, which has found that neurological conditions are the leading cause of ill health and disability worldwide, with over 3.4 billion people worldwide are affected.

THCS (transforming health and care systems) has launched its second Joint Transnational Call for proposals aiming to support the implementation of innovative person-centred health and care models addressing prevention strategies, with the key help of existing IT and digital technologies and services.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2024.

Our Paper of the month for March is a retrospective longitudinal study emphasizing the important role of cortical myelin dynamics in determining neurodegeneration and clinical progression in MS.

The European Academy of Neurology has published a strategic neurological research agenda as a position paper in the European Journal of Neurology, to address current gaps and set priority areas for new clinically relevant research.

Our paper of the month for February is an open-label extension study to assess the long-term efficacy and safety of cerliponase in padiatric patients with CLN2 disease.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2024.

Did you know that EAN members can submit survey proposals to explore a specific area of scientific interest? The EAN offers scientific support throughout the whole process including survey design, set-up, and dissemination.

A retrospective, multicentre, cross-sectional study aiming to evaluate the performance of cortical lesions and the central vein sign in differentiating multiple sclerosis from other conditions with brain white matter lesions.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for January 2024.

Application is currently open for this year’s David Marsden Award with a deadline for submissions of 29 February 2024.

This study presents the results of a clinical trial investigating whether apixaban, compared to aspirin, would be associated with reduced risk of stroke or systemic embolism, with a tolerably low risk of major bleeding.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2023.